These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
295 related articles for article (PubMed ID: 23896327)
1. L-type amino acid transporter 1 (LAT1): a new therapeutic target for canine mammary gland tumour. Fukumoto S; Hanazono K; Komatsu T; Ueno H; Kadosawa T; Iwano H; Uchide T Vet J; 2013 Oct; 198(1):164-9. PubMed ID: 23896327 [TBL] [Abstract][Full Text] [Related]
2. A new treatment for human malignant melanoma targeting L-type amino acid transporter 1 (LAT1): a pilot study in a canine model. Fukumoto S; Hanazono K; Fu DR; Endo Y; Kadosawa T; Iwano H; Uchide T Biochem Biophys Res Commun; 2013 Sep; 439(1):103-8. PubMed ID: 23954667 [TBL] [Abstract][Full Text] [Related]
3. L-type amino acid transporter 1 (LAT1) expression in canine mammary gland tumors. Fukumoto S; Hanazono K; Komatsu T; Iwano H; Kadosawa T; Uchide T J Vet Med Sci; 2013 May; 75(4):431-7. PubMed ID: 23171689 [TBL] [Abstract][Full Text] [Related]
5. Impact of system L amino acid transporter 1 (LAT1) on proliferation of human ovarian cancer cells: a possible target for combination therapy with anti-proliferative aminopeptidase inhibitors. Fan X; Ross DD; Arakawa H; Ganapathy V; Tamai I; Nakanishi T Biochem Pharmacol; 2010 Sep; 80(6):811-8. PubMed ID: 20510678 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of system L (LAT1/CD98hc) reduces the growth of cultured human breast cancer cells. Shennan DB; Thomson J Oncol Rep; 2008 Oct; 20(4):885-9. PubMed ID: 18813831 [TBL] [Abstract][Full Text] [Related]
8. System L amino acid transporter inhibitor enhances anti-tumor activity of cisplatin in a head and neck squamous cell carcinoma cell line. Yamauchi K; Sakurai H; Kimura T; Wiriyasermkul P; Nagamori S; Kanai Y; Kohno N Cancer Lett; 2009 Apr; 276(1):95-101. PubMed ID: 19058911 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of L-type amino acid transporter 1 has antitumor activity in non-small cell lung cancer. Imai H; Kaira K; Oriuchi N; Shimizu K; Tominaga H; Yanagitani N; Sunaga N; Ishizuka T; Nagamori S; Promchan K; Nakajima T; Yamamoto N; Mori M; Kanai Y Anticancer Res; 2010 Dec; 30(12):4819-28. PubMed ID: 21187458 [TBL] [Abstract][Full Text] [Related]
10. Characterization of the system L amino acid transporter in T24 human bladder carcinoma cells. Kim DK; Kanai Y; Choi HW; Tangtrongsup S; Chairoungdua A; Babu E; Tachampa K; Anzai N; Iribe Y; Endou H Biochim Biophys Acta; 2002 Sep; 1565(1):112-21. PubMed ID: 12225859 [TBL] [Abstract][Full Text] [Related]
11. Differential expression and functional characterization of system L amino acid transporters in human normal osteoblast cells and osteogenic sarcoma cells. Kim SG; Kim HH; Kim HK; Kim CH; Chun HS; Kanai Y; Endou H; Kim DK Anticancer Res; 2006; 26(3A):1989-96. PubMed ID: 16827134 [TBL] [Abstract][Full Text] [Related]
12. System L-amino acid transporters are differently expressed in rat astrocyte and C6 glioma cells. Kim DK; Kim IJ; Hwang S; Kook JH; Lee MC; Shin BA; Bae CS; Yoon JH; Ahn SG; Kim SA; Kanai Y; Endou H; Kim JK Neurosci Res; 2004 Dec; 50(4):437-46. PubMed ID: 15567481 [TBL] [Abstract][Full Text] [Related]
13. Properties of L-type amino acid transporter 1 in epidermal ovarian cancer. Kaji M; Kabir-Salmani M; Anzai N; Jin CJ; Akimoto Y; Horita A; Sakamoto A; Kanai Y; Sakurai H; Iwashita M Int J Gynecol Cancer; 2010 Apr; 20(3):329-36. PubMed ID: 20375792 [TBL] [Abstract][Full Text] [Related]
14. c-Myc is crucial for the expression of LAT1 in MIA Paca-2 human pancreatic cancer cells. Hayashi K; Jutabha P; Endou H; Anzai N Oncol Rep; 2012 Sep; 28(3):862-6. PubMed ID: 22736142 [TBL] [Abstract][Full Text] [Related]
15. Expression and functional characterization of the system L amino acid transporter in KB human oral epidermoid carcinoma cells. Yoon JH; Kim YB; Kim MS; Park JC; Kook JK; Jung HM; Kim SG; Yoo H; Ko YM; Lee SH; Kim BY; Chun HS; Kanai Y; Endou H; Kim DK Cancer Lett; 2004 Mar; 205(2):215-26. PubMed ID: 15036654 [TBL] [Abstract][Full Text] [Related]
16. Androgen receptor and nutrient signaling pathways coordinate the demand for increased amino acid transport during prostate cancer progression. Wang Q; Bailey CG; Ng C; Tiffen J; Thoeng A; Minhas V; Lehman ML; Hendy SC; Buchanan G; Nelson CC; Rasko JE; Holst J Cancer Res; 2011 Dec; 71(24):7525-36. PubMed ID: 22007000 [TBL] [Abstract][Full Text] [Related]
17. Analysis of L-type amino acid transporter in canine hepatocellular carcinoma. Ogihara K; Naya Y; Sato R; Onda K; Ochiai H J Vet Med Sci; 2015 May; 77(5):527-34. PubMed ID: 25649314 [TBL] [Abstract][Full Text] [Related]
18. Transport of 3-fluoro-L-α-methyl-tyrosine by tumor-upregulated L-type amino acid transporter 1: a cause of the tumor uptake in PET. Wiriyasermkul P; Nagamori S; Tominaga H; Oriuchi N; Kaira K; Nakao H; Kitashoji T; Ohgaki R; Tanaka H; Endou H; Endo K; Sakurai H; Kanai Y J Nucl Med; 2012 Aug; 53(8):1253-61. PubMed ID: 22743251 [TBL] [Abstract][Full Text] [Related]
19. L-type amino acid transporter 1 as a potential molecular target in human astrocytic tumors. Nawashiro H; Otani N; Shinomiya N; Fukui S; Ooigawa H; Shima K; Matsuo H; Kanai Y; Endou H Int J Cancer; 2006 Aug; 119(3):484-92. PubMed ID: 16496379 [TBL] [Abstract][Full Text] [Related]
20. Functional activity of a large neutral amino acid transporter (LAT) in rabbit retina: a study involving the in vivo retinal uptake and vitreal pharmacokinetics of L-phenyl alanine. Atluri H; Talluri RS; Mitra AK Int J Pharm; 2008 Jan; 347(1-2):23-30. PubMed ID: 17686592 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]